Recent Updates
Recently added Catalysts
IMRN Positive Sentiment Score: 70/100

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Monday, September 11, 2023 1 min read
Key Takeaway: Immuron Limited announced that its CEO, Steven Lydeamore, will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th. The presentation aims to highlight the company's developments in developing orally delivered targeted polyclonal antibodies for infectious diseases. An available webcast will provide interested parties access to the presentation. Immuron is an Australian biopharmaceutical firm listed on both the ASX and NASDAQ.

Market Sentiment Analysis

POSITIVE FACTORS

  • CEO Steven Lydeamore is presenting at a reputable investment conference.
  • The presentation offers visibility for Immuron in the biopharmaceutical sector.
  • The company’s focus on innovative therapies positions it well for future growth.

Full Press Release Details

MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting virtually at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th.
The webcast to this presentation will be available here at 7am Eastern Daylight Time / 9pm Australian Eastern Standard time on September 11th.
A copy of the presentation being made at the H.C. Wainwright 25th Annual Global Investment Conference is available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
This release has been authorised by the directors of Immuron Limited.
Chief Executive Officer
Ph: +61 (0)3 9824 5254
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Tags

H.C. Wainwright & Co

Frequently Asked Questions

When did Immuron's CEO present at the investment conference?

Immuron's CEO, Steven Lydeamore, presented on September 11, 2023.

Where can I watch the presentation webcast?

The webcast is available at 7am EDT on September 11th on their website.

What does Immuron Limited focus on?

Immuron Limited focuses on developing orally delivered targeted polyclonal antibodies.

Where can I find the presentation copy?

A copy of the presentation is available on Immuron’s corporate presentations webpage.

Tags: IMRN Viatris Investor Conferences Healthcare Immuron Steven Lydeamore H.C. Wainwright biopharmaceuticals NASDAQ: IMRN
Last updated: Sep 11, 2023